首页> 中文期刊> 《中国社区医师》 >Ⅲ~Ⅳ期非小细胞肺癌采用加减沙参麦冬汤联合化疗治疗的临床效果分析

Ⅲ~Ⅳ期非小细胞肺癌采用加减沙参麦冬汤联合化疗治疗的临床效果分析

         

摘要

目的:探讨Ⅲ~Ⅳ期非小细胞肺癌采用加减沙参麦冬汤联合化疗治疗的临床效果。方法:收治Ⅲ~Ⅳ期非小细胞肺癌患者140例,分为观察组和对照组,每组70例。对照组给予常规化疗治疗,观察组在对照组的基础上给予加减沙参麦冬汤治疗,比较两组的治疗效果。结果:观察组治疗总有效率明显高于对照组(P<0.05);治疗后观察组生活质量明显优于对照组(P<0.05);观察组不良反应发生率明显低于对照组(P<0.05)。结论:采用加减沙参麦冬汤联合化疗治疗Ⅲ~Ⅳ期非小细胞肺癌具有较好的效果,且可改善生活质量,减少不良反应,有较高的应用价值。%Objective:To explore the clinical effect of using adjusted Sha Shen Mai Dong decoction combined with chemotherapy treatment in Ⅲ~Ⅳ period non-small cell lung cancer.Methods:140 patients with Ⅲ~Ⅳ period non-small cell lung cancer were selected.They were divided into the observation group and the control group with 70 cases in each group.The control group was given conventional chemotherapy treatment.The observation group was given adjusted Sha Shen Mai Dong decoction treatment on the basis of the control group.The treatment effects of two groups were compared.Results:The treatment total effective rate of the observation group was significantly higher than that of the control group(P<0.05).After the treatment,the life quality of the observation group was significantly better than that of the control group(P<0.05).The incidence rate of adverse reaction in the observation group was significantly lower than that of the control group(P<0.05).Conclusion:Using adjusted Sha Shen Mai Dong decoction combined with chemotherapy in the treatment of Ⅲ~Ⅳ period non-small cell lung cancer has better effect.It can improve the life quality,reduce the adverse reactions and has a higher application value.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号